Clopidogrel Bisulfate is a thienopyridine derivative. The separation, identification and degradation of Clopidogrel Bisulfate under hydrolytic and oxidative stress conditions according to the International Conference on Harmonization (ICH) guideline Q1A (R2) was performed. TLC using (n-hexan:tetrahydrofuran)(1:1 v/v) as a mobile phase was used to separate the degradation products. Three compounds were isolated then analyzed using RP-HPLC which showed a purity of 99%. Mass fragmentation pathway of the compounds were first established with the help of GC/MS studies. Then, the degradation products were subjected to FTIR and 1H NMR studies. The obtained data were employed to characterize the degradation products and assign structures. The degradation products were identified as (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl) acetic acid in acidic and basic media, 2-(2-chlorophenyl)-2-oxoacetic acid and 4,5,6,7-tetrahydrothieno [3,2-c] pyridine in oxidative medium.
INTRODUCTION
Clopidogrel hydrogen sulfate, methyl ( + ) -( S ) -α -( o -c h l o r o p h e n y l ) -6 , 7 -dihydrothieno [3,2-c] pyridin-5(4H)-acetate hydrogen sulfate, is a novel thienopyridine derivative that irreversibly blocks adenosine diphosphate (ADP) and is important in platelet aggregation, the cross-linking of platelets by fibrin. Clopidogrel bisulphate (Figure 1 ) is chemically related to Ticlopidine with superior side effects profile and dosing requirements.
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The empirical formula of Clopidogrel bisulfate is C 16 H 16 ClNO 2 S•H 2 SO 4 and its molecular weight is 419. 9 . 4 The molecule of Clopidogrel contains an asymmetrical carbon leading to the existence of two enantiomers (R and S). Studies showed that the active compound Clopidogrel is the S enantiomer. 5, 6 Clopidogrel free base was unstable due to a labile proton in the chiral center and was susceptible to racemization and hydrolysis of methyl ester group. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix ® , a Plavix tablet contains 75 mg of Clopidogrel bisulfate. 3 Characterization of Clopidogrel bisulfate degradation under solid stress conditions was performed in previous literature, 8 determination of Clopidogrel bisulfate in active pharmaceutical ingredient by chromatography has also been revealed, 9 a new study for the identification and characterization of a principle oxidation impurity in Clopidogrel drug substances and drug product was conducted, 10 for the quantitative determination of Clopidogrel bisulfate active metabolite in human plasma an LC/ MS method was used, 11 and an LC method for the determination of Clopidogrel in pharmaceutical preparations wasvalidated.
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Simultaneous determination of Clopidogrel and Aspirin in pharmaceutical dosage form was mentioned 13 and RP-HPLC was used for the analysis of aspirin and Clopidogrel bisulfate in combination.
14 Recently, the non-enzymatic and enzymatic chiral inversion of Clopidogrel has been investigated in vitro using 1 H-NMR and a chiral HPLC procedure. 15 For the analysis of the carboxylic acid metabolite of Clopidogrel in plasma and serum a GC-MS method has also been reported. 16 United States Pharmacopeia-30 (USP-30) 17 has enumerated related substance method for Clopidogrel tablets in their monograph, the known related compounds of Clopidogrel were given in Figure 2 . In addition, British pharmacopeia 2013 has mentioned a related compound named D, as shown in Figure 3 .
18 Also literature survey revealed that four impurities of Clopidogrel have been already identified. 12, 19 Though these methods already exist in the literature, none of the methods carried out studies to isolate and characterize degradation products of Clopidogrel bisulfate formed by hydrolysis or oxidation under stress condition according to ICH. An attempt was made towards isolation and characterization of degradation products. Therefore, an endeavor of the present study was to decompose the drug under hydrolytic and oxidation conditions, to resolve the products on preparative TLC and to characterize the major products by NMR, GC/ MS and FTIR studies.
MATERIALS AND METHODS

Chemicals
Clopidogrel bisulfate was obtained as gift sample from Al-Razi laboratories (Aleppo, Syria) and was used without further purification. Analytical reagent grade hydrogen peroxide (H 2 O 2 ). Sodium hydroxide (NaOH) was purchased from Hi Media (Mumbai, India). Hydrochloric acid (HCl), Methanol, Dichloromethan, n-hexan, and tetrahydrofuran were supplied by Merck.
APPARATUS AND EQUIPMENT
Analytical HPLC was performed as mentioned in our previous study. 20 
GC-MS
GC-MS analyses were performed on Shimadzu -GCMS-QP2010 Plus device equipped with META-5X column (30.0 m X 0.32 mm X 0.25 mm), carrier gas was He, and gas flow rate 1.27 ml/min. Mass spectra were obtained by electron impact (EI) ionization at 70 eV with an emission current of 400 mA. The scan time was 1 s and the scan range was m/z 29-600. The ion source temperature was maintained at 280ºC. The identity confirmed by fragmentation pattern and by NIST &WILEY mass spectral libraries. The temperature program was as follows:
• 80ºC, hold for 5 min;
• Temperature rise from 80ºC to 200ºC at a rate 20ºC /min; • Temperature rise from 200ºC to 295ºC at a rate 10ºC/min and hold for 5 min.
H NMR Spectroscopy
About 10 mg of the tested substances were each dissolved in 0.6 mL of DMSO-d6 and were immediately analyzed by NMR spectroscopy. The one dimensional 
IR Spectroscopy
The IR spectrum was recorded in the solid state as a KBr disk, and in Nujol as a dispersion medium, using the FT-IR (Bruker, alpha) spectrophotometer, the wave length resolution was set to 4 cm -1 , the IR spectrum was collected in a range of 400-4000 cm -1 , with Bruker Opus 5.5 software.
Preparative TLC Method
A mobile phase of (n-hexan:tetrahydrofuran)(1:1 V) was used, 20 X 20 cm glass TLC plates coated with (SIL. G. UV 254+366 ) were purchased from MACHEREY-NAGEL GmbH & Co. KG, Germany.
Preparation of degradation samples of Clopidogrel
Acid and base degradation
Accurately weighed 500 mg of Clopidogrel was dissolved in 50 ml of methanol. The drug was subjected to accelerated degradation under acidic and basic conditions by refluxing with (10 ml) 1N HCl and (10 ml) 1N NaOH, respectively, at 70°C for a period of 3 and 1 hr, respectively. The accelerated degradation in acidic and basic media was performed in the dark in order to exclude the possible degradation effect of light on the drug.
19
Peroxide degradation
Accurately weighed 500 mg of drug was dissolved in 50 ml of methanol. Subsequently, 10 ml of hydrogen peroxide 30.0% v/v was added and the solution was heated in boiling water bath for 1 hour.
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Data Analysis
Structure formulae were generated and processed by Chem Bio Draw Ultra 12.0 Software. 
RESULTS AND DISCUSSION
Isolation of Degradation Product(s) by Preparative TLC
The resultant solutions after acid, base and oxidative degradation were isolated as follows, the aqueous layer was washed with dichloromethane to remove Clopidogrel, then the aqueous layer was subjected to preparative TLC, the bands were visualized using UV 254 lamp, the desired band was scratched with a spatula, extracted with methanol which was finally evaporated. The resulted solid was analyzed using RP-HPLC 20 and the purity of the compound was found to be 99% which was good enough for carrying out the spectroscopic experiments.
Characterization of the Degradation Product
Characterization of the compounds was performed using analytical data obtained from IR, GC/MS and 1 H NMR spectrum experiments.
Elucidation of the Structure of Degradation Product Resulted from hydrolytic stress Conditions (compound A)
It was found that there was one degradation product (compound A). The MS, IR, and NMR spectra of product A were recorded. The major Mass fragments obtained by GC-MS analysis are given in Table(1) . Figure ( Tables (2) . On the basis of these data it was inferred that the methoxy group of Clopidogrel was not present in compound A.
As shown in
The degradation product was formed by hydrolysis of ester group of Clopidogrel to form methanol and Clopidogrel acid. (5) and table (2), the main functional groups of compound A (Clopidogrel acid) appeared clearly; the absence of ester group, the presence of -OH carboxylic at 3450 cm -1 , and the presence of -C-Ocarboxylic at 1188 cm -1 .
As shown in Figure
As shown in Figure 7 , 1 H, 14) .
On the basis of these data it was concluded that compound A was (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothi- 
Elucidation of the Structure of Degradation Products Resulted from oxidative stress conditions
It was found that there were two degradation products (compound B and compound C). The MS, IR, and NMR spectra of product B were recorded. The major Mass fragments for product B is given in Table ( 3). The degradation products were formed by fragmentation of Clopidogrel to form product B and product C. GC-MS analysis of product B revealed a molecular ion peak at m/z: 139/140 and the fragmentation pattern also confirmed the structure given in Figure (9) . IR spectrum and bands and assignments of product B are also shown in Figure ( On the basis of these data it was concluded that the product B was 4,5,6,7-tetrahydrothieno[3,2-c]pyridine Figure (13) . The MS, IR, and NMR spectra of product C were recorded. The major Mass fragments for product C is given in Table (5) . GC-MS analysis of product C revealed a molecular ion peak at m/z: 184/186 and the fragmentation pattern which is shown in Table ( 5) also confirmed the structure given in Figure (14) . IR spectrum and bands and assignments of product C are also shown in Figure (15 . As shown in Figure 16 , the 1 H NMR spectrum of product C was (400 MHz, DMSO-d6) δ ppm 5.80 (s, 1 H, 10) 7.44 -7.52 (td, 1 H, 4) 7.52 -7.59 (dd, 1 H, 3) 7.60 -7.69 (td, 1 H, 5) 7.77 (dd, J=7.80 Hz, 1 H, 6), Figure (17) . On the basis of these data it was concluded that product C was 2-(2-chlorophenyl)-2-oxoacetic acid Figure (18 ).
CONCLUSION
The hydrolytic and oxidative degradation product of Clopidogrel bisulfate was isolated by preparative TLC and was characterized using spectroscopic techniques namely NMR, IR, and MS. The degradation products were identified as Clopidogrel acid which is chemically: (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno [3,2- 
